These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6597876)

  • 1. [Serum CA-125 level in patients with gynecologic tumors].
    Abe Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Saito J; Nishino T
    Rinsho Byori; 1984 Dec; 32(12):1350-4. PubMed ID: 6597876
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
    Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
    Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M
    Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
    Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of the determination of serum CA19.9 in patients with tumor or non-tumor pancreatopathies].
    Encabo G; Ruibal A; Gefaell R; Martínez Miralles E; Salgado A; Fernández Llamazares J
    Med Clin (Barc); 1984 Mar; 82(12):560-1. PubMed ID: 6588282
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the use of CA-125 in gynecologic mass screening].
    Nakatani K; Hoshiai H; Wada Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):157-60. PubMed ID: 3469285
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
    Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum levels of CA-125 in patients with endometriosis.
    Giudice LC; Jacobs AJ; Bell CE; Lippmann L
    Gynecol Oncol; 1986 Oct; 25(2):256-8. PubMed ID: 3463522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of the serum levels of Ca 19-9 and CA 50 in gastric cancer].
    Loizate Totorikaguena A; Lamiquiz Vallejo A; Domínguez Merru-Urrutia MJ
    Rev Esp Enferm Apar Dig; 1987 Nov; 72(5 Pt 2):644-5. PubMed ID: 2452465
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum CA 1,25 in patients with non-ovarian tumors. Evidence of a relation between the increase of the antigen and hepatic disease].
    Ruibal A; Siurana R; Encabo G; Cuartero A
    Med Clin (Barc); 1985 Mar; 84(9):376-7. PubMed ID: 3857424
    [No Abstract]   [Full Text] [Related]  

  • 11. [CA 19-9 in benign diseases of the gastrointestinal tract].
    Klapdor R
    Dtsch Med Wochenschr; 1986 Jun; 111(26):1039. PubMed ID: 3459644
    [No Abstract]   [Full Text] [Related]  

  • 12. [Laboratory tests for the diagnosis and follow-up of cancer].
    Stenman UH
    Duodecim; 1986; 102(9):525-33. PubMed ID: 2424709
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors.
    Göcze PM; Szabó DG; Than GN; Csaba IF; Krommer KF
    Gynecol Obstet Invest; 1988; 25(4):268-72. PubMed ID: 2841208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new carbohydrate antigen CA 19-9 associated with malignancies of digestive system. I. Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Yamanaka T; Kimura K; Yagisawa K; Igarashi S; Yonezawa M; Ioku A
    Rinsho Byori; 1984 May; 32(5):539-45. PubMed ID: 6592377
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum CA 15.3 levels in patients with general pathology and malignant diseases (excluding breast cancer).
    Ruibal A; Encabo G; Genollá J; Guarga A; Urrutia A; Colomer R
    Bull Cancer; 1986; 73(1):94-5. PubMed ID: 3465383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor markers in the diagnosis of tumors in the subhepatic area].
    Dufek V; Petrtýl J; Klener P; Chmel J
    Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CA125 in patients with pleural effusion--in comparison with ascites patients].
    Kawabe T; Hirano M; Mohri M; Sugimoto T; Nagata Y; Hisada M; Muto H; Unuma T; Momose T; Naka H
    Rinsho Byori; 1987 Aug; 35(8):905-9. PubMed ID: 3480365
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of a cancer antigen CA 125 associated with ovarian cancer. II. Serum CA 125 levels in normal pregnancy].
    Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1985 Jan; 33(1):73-6. PubMed ID: 3857365
    [No Abstract]   [Full Text] [Related]  

  • 19. A radioimmunoassay for ovarian cancer.
    N Engl J Med; 1984 Mar; 310(11):724-5. PubMed ID: 6583507
    [No Abstract]   [Full Text] [Related]  

  • 20. CA-125 and endometriosis.
    Barbieri RL
    Contrib Gynecol Obstet; 1987; 16():103-8. PubMed ID: 2446822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.